Skip to content

Exercise and Diet in Type 2 Diabetic Women

Clinical Trial of Exercise and Diet in Type 2 Diabetic Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00763074
Enrollment
70
Registered
2008-09-30
Start date
2006-04-30
Completion date
2007-03-31
Last updated
2008-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Sensitivity, Type 2 Diabetes

Keywords

Intra-Abdominal Fat, Adipokines, Exercise, Diet therapy

Brief summary

The purpose of this study was to evaluate the effects of 12 weeks' increased daily physical activity versus diet restriction on regional fat distribution, insulin sensitivity and adipokines including retinol binding protein-4 (RBP-4), leptin, adiponectin, and a new marker, adiponectin to leptin ratio (AL ratio), in type 2 diabetic women.

Interventions

BEHAVIORALStandard life style modification for type 2 diabetes

Two session of education for exercise and diet. \----------- Exercise: 30min/day x 4/week Diet: ideal body weight x 30\ 35kcal/day

Education for diet and exercise every 2 weeks \----------- Dietary calorie restriction: reduce their usual intake by -500kcal/day

BEHAVIORALExercise

Education for diet and exercise every 2 weeks \----------- Exercise: more than 60min/day of exercise with moderate activity level twice per day

BEHAVIORALDiet and exercise

Education for diet and exercise every 2 weeks \----------- Exercise education like as exercise group and diet education like as diet group

Sponsors

Eulji University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Type 2 diabetic patient * BMI\>23kg/m2 * Female

Exclusion criteria

* The patients with co-morbidity such as heart failure, chronic kidney disease or liver cirrhosis

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026